Antiarrhythmic Drugs

** This drug is used to treat and suppress ventricular arrhythmias, particularly ventricular fibrillation and ventricular tachycardia especially unresponsive to lidocaine

Objective: The aim of the present study was to assess the predictive value of the CHADS 2 , CHA 2 DS 2 -VASc, R 2 CHADS 2 , and APPLE scores for rhythm outcome in patients with

The recently published consensus document by the European Heart Rhythm Association presents a patient-tailored pharmacological antiarrhyth- mic treatment approach targeting

In this paper, we reviewed the atrial fibrillation screening strategies in a stepwise manner and discussed the uncertainties in the assessment of the need for anticoagulation in

A velocity, E/E′ ratio, diastolic dysfunction values, LV stroke vol- ume were higher in mild-to-moderate OSA patients compared with those in the control group and E velocity, E/A

He was transported to our hospital for primary percutaneous coronary intervention with the diagnosis of inferior myocardial infarction (MI). Which

Effect of elevated left ventricular diastolic filling pressure on the frequency of left atrial appendage thrombus in patients with nonvalvular atrial fibrillation. Nagueh S,

Objective: The aim of this study was to compare the requirement for temporary and permanent pacemaker insertion and the incidence of the problems regarding the rhythm following